Citi maintains buy on CSL after mammoth takeover
MELBOURNE: Citi analysts have maintained their ‘buy’ rating on biotech giant CSL, noting ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
